First Time Loading...

CellSource Co Ltd
TSE:4880

Watchlist Manager
CellSource Co Ltd Logo
CellSource Co Ltd
TSE:4880
Watchlist
Price: 1 522 JPY 0.33% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

CellSource Co., Ltd. engages in regenerative medicine related business. [ Read More ]

The intrinsic value of one CellSource Co Ltd stock under the Base Case scenario is 1 246.36 JPY. Compared to the current market price of 1 522 JPY, CellSource Co Ltd is Overvalued by 18%.

Key Points:
Intrinsic Value
Base Case
1 246.36 JPY
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CellSource Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CellSource Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
CellSource Co Ltd

Provide an overview of the primary business activities
of CellSource Co Ltd.

What unique competitive advantages
does CellSource Co Ltd hold over its rivals?

What risks and challenges
does CellSource Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CellSource Co Ltd.

Provide P/S
for CellSource Co Ltd.

Provide P/E
for CellSource Co Ltd.

Provide P/OCF
for CellSource Co Ltd.

Provide P/FCFE
for CellSource Co Ltd.

Provide P/B
for CellSource Co Ltd.

Provide EV/S
for CellSource Co Ltd.

Provide EV/GP
for CellSource Co Ltd.

Provide EV/EBITDA
for CellSource Co Ltd.

Provide EV/EBIT
for CellSource Co Ltd.

Provide EV/OCF
for CellSource Co Ltd.

Provide EV/FCFF
for CellSource Co Ltd.

Provide EV/IC
for CellSource Co Ltd.

Show me price targets
for CellSource Co Ltd made by professional analysts.

What are the Revenue projections
for CellSource Co Ltd?

How accurate were the past Revenue estimates
for CellSource Co Ltd?

What are the Net Income projections
for CellSource Co Ltd?

How accurate were the past Net Income estimates
for CellSource Co Ltd?

What are the EPS projections
for CellSource Co Ltd?

How accurate were the past EPS estimates
for CellSource Co Ltd?

What are the EBIT projections
for CellSource Co Ltd?

How accurate were the past EBIT estimates
for CellSource Co Ltd?

Compare the revenue forecasts
for CellSource Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CellSource Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CellSource Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of CellSource Co Ltd compared to its peers.

Compare the P/E ratios
of CellSource Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing CellSource Co Ltd with its peers.

Analyze the financial leverage
of CellSource Co Ltd compared to its main competitors.

Show all profitability ratios
for CellSource Co Ltd.

Provide ROE
for CellSource Co Ltd.

Provide ROA
for CellSource Co Ltd.

Provide ROIC
for CellSource Co Ltd.

Provide ROCE
for CellSource Co Ltd.

Provide Gross Margin
for CellSource Co Ltd.

Provide Operating Margin
for CellSource Co Ltd.

Provide Net Margin
for CellSource Co Ltd.

Provide FCF Margin
for CellSource Co Ltd.

Show all solvency ratios
for CellSource Co Ltd.

Provide D/E Ratio
for CellSource Co Ltd.

Provide D/A Ratio
for CellSource Co Ltd.

Provide Interest Coverage Ratio
for CellSource Co Ltd.

Provide Altman Z-Score Ratio
for CellSource Co Ltd.

Provide Quick Ratio
for CellSource Co Ltd.

Provide Current Ratio
for CellSource Co Ltd.

Provide Cash Ratio
for CellSource Co Ltd.

What is the historical Revenue growth
over the last 5 years for CellSource Co Ltd?

What is the historical Net Income growth
over the last 5 years for CellSource Co Ltd?

What is the current Free Cash Flow
of CellSource Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for CellSource Co Ltd.

Financials

Balance Sheet Decomposition
CellSource Co Ltd

Current Assets 5.4B
Cash & Short-Term Investments 4.7B
Receivables 321.5m
Other Current Assets 388.1m
Non-Current Assets 1.4B
PP&E 793.1m
Intangibles 42.7m
Other Non-Current Assets 583.4m
Current Liabilities 626.2m
Accounts Payable 83.8m
Accrued Liabilities 31.5m
Other Current Liabilities 510.9m
Non-Current Liabilities 220.5m
Other Non-Current Liabilities 220.5m
Efficiency

Earnings Waterfall
CellSource Co Ltd

Revenue
4.6B JPY
Cost of Revenue
-1.5B JPY
Gross Profit
3.2B JPY
Operating Expenses
-2.1B JPY
Operating Income
1.1B JPY
Other Expenses
-225.1m JPY
Net Income
851m JPY

Free Cash Flow Analysis
CellSource Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

CellSource Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional ROIC
76/100
Profitability
Score

CellSource Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CellSource Co Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

CellSource Co Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CellSource Co Ltd

Wall Street analysts forecast CellSource Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CellSource Co Ltd is 1 836 JPY with a low forecast of 1 818 JPY and a high forecast of 1 890 JPY.

Lowest
Price Target
1 818 JPY
19% Upside
Average
Price Target
1 836 JPY
21% Upside
Highest
Price Target
1 890 JPY
24% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
CellSource Co Ltd

1M 1M
+3%
6M 6M
-22%
1Y 1Y
-40%
3Y 3Y
-88%
5Y 5Y
+95%
10Y 10Y
+95%
Annual Price Range
1 522
52w Low
1 194
52w High
3 095
Price Metrics
Average Annual Return 191.12%
Standard Deviation of Annual Returns 401.42%
Max Drawdown -95%
Shares Statistics
Market Capitalization 30.1B JPY
Shares Outstanding 19 899 896
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

CellSource Co Ltd Logo
CellSource Co Ltd

Country

Japan

Industry

Life Sciences Tools & Services

Market Cap

30.1B JPY

Dividend Yield

0.66%

Description

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 90 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Contact

TOKYO-TO
Shibuya-Ku
2F, Shibuya Mitake Bldg., 1-19-5, Shibuya
+81364555308.0
https://www.cellsource.co.jp

IPO

2019-10-28

Employees

90

Officers

Executive Chairman & MD
Mr. Masayuki Yamakawa M.D.
Representative Director, President & CEO
Mr. Takashi Sawada
Representative Director, CXO & CTO
Mr. Masato Tsumamoto
Executive Officer & VP of Medical Affairs Unit
Mr. Hirohiko Hanaki
Executive Officer & Head of Management Headquarters
Mr. Katsuji Onishi
Executive Officer & VP of Corporate Planning Unit
Kaoru Hosoda
Show More
Executive Officer & Head of CPC Headquarters
Mr. Futa Asada
Show Less

See Also

Discover More
What is the Intrinsic Value of one CellSource Co Ltd stock?

The intrinsic value of one CellSource Co Ltd stock under the Base Case scenario is 1 246.36 JPY.

Is CellSource Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 522 JPY, CellSource Co Ltd is Overvalued by 18%.